BELLUCCI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.144
EU - Europa 3.729
AS - Asia 2.062
SA - Sud America 186
AF - Africa 43
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.101
RU - Federazione Russa 995
PL - Polonia 936
IT - Italia 616
SG - Singapore 600
CN - Cina 435
HK - Hong Kong 331
VN - Vietnam 308
SE - Svezia 287
IE - Irlanda 279
KR - Corea 155
BR - Brasile 149
DE - Germania 142
UA - Ucraina 121
FI - Finlandia 114
FR - Francia 85
GB - Regno Unito 80
IN - India 72
JP - Giappone 45
AU - Australia 31
MX - Messico 21
JO - Giordania 16
AR - Argentina 15
CA - Canada 15
ID - Indonesia 15
ES - Italia 13
BD - Bangladesh 12
IQ - Iraq 12
NL - Olanda 12
TR - Turchia 12
BE - Belgio 11
CI - Costa d'Avorio 11
CH - Svizzera 10
NG - Nigeria 7
CL - Cile 6
NP - Nepal 6
RO - Romania 6
CO - Colombia 5
PK - Pakistan 5
SC - Seychelles 5
AZ - Azerbaigian 4
EC - Ecuador 4
HR - Croazia 4
KE - Kenya 4
PH - Filippine 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
PY - Paraguay 3
TH - Thailandia 3
AT - Austria 2
CR - Costa Rica 2
CY - Cipro 2
HN - Honduras 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
OM - Oman 1
PS - Palestinian Territory 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
Totale 11.197
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.049
Warsaw 930
Ashburn 711
Singapore 428
Fairfield 321
Chandler 301
Dublin 278
Hong Kong 273
Woodbridge 191
Jacksonville 171
Cambridge 155
Seattle 154
Seoul 153
Houston 147
San Jose 135
Wilmington 132
Dong Ket 124
Milan 117
Beijing 103
Buffalo 98
Ann Arbor 91
Los Angeles 81
Princeton 69
The Dalles 68
Ho Chi Minh City 67
Boston 62
Council Bluffs 62
Rome 55
Altamura 54
Lauterbourg 53
Mumbai 52
Florence 48
Hefei 45
Tokyo 44
Lawrence 41
Boardman 40
Dallas 34
Hanoi 34
Munich 32
Melbourne 31
Helsinki 28
Moscow 24
New York 24
Shanghai 23
Turku 21
Falls Church 20
Guangzhou 20
Kent 20
Medford 20
Norwalk 17
Redondo Beach 16
Turin 16
Paris 15
San Diego 15
Washington 14
Bari 13
São Paulo 13
Frankfurt am Main 12
Phoenix 12
Verona 12
West Jordan 12
Abidjan 11
Bologna 11
Brussels 11
Naples 11
Orem 11
Dearborn 10
Hillsboro 10
Bern 9
Haiphong 9
Jakarta 9
Chicago 8
Clifton 8
Da Nang 8
Figino 8
Genoa 8
Philadelphia 8
Toronto 8
Barcelona 7
Yubileyny 7
Abuja 6
Amman 6
Andover 6
Chennai 6
Curitiba 6
Frankfurt Am Main 6
London 6
Baghdad 5
Brooklyn 5
Charlotte 5
Denver 5
Lappeenranta 5
Mexico City 5
Montreal 5
Palermo 5
Pescara 5
Redwood City 5
Stockholm 5
Ankara 4
Atlanta 4
Totale 7.678
Salva come PNG Salva come JPEG
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 526
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 339
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 333
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 307
Memory facilitation with atropine: a paradoxical effect 298
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 297
In vitro characterization of a novel, potent and selective M3 antagonist 283
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 260
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 230
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 226
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 211
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 208
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 207
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 207
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 206
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 203
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 201
Carbachol dimers as homobivalent modulators of muscarinic receptors 197
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 196
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 189
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 185
SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL PROFILE OF TROPICAMIDE ENANTIOMERS 176
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 176
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 175
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 175
Attività analgesica e antimuscarinica ed enantioselettività dei quattro isomeri del tropato del 3-chinuclidinolo messe a confronto con gli enantiomeri della iosciamina 171
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 170
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 170
Muscarine-like compounds derived from a pyrolysis product of cellulose 163
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. 160
New insights in the metabolism of Oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 157
Design, synthesis and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain 155
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists 154
Differential analgesic activity of the enantiomers of atropine derivatives does not correlate with their muscarinic subtype selectivity 152
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 152
Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists. 148
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 147
NEGATIVE INOTROPIC ACTIVITY OF PARA-SUBSTITUTED DIETHYL BENZYL PHOSPHONATES RELATED TO FOSTEDIL 141
New multidrug resistance (MDR) agents endowed with good potency and efficacy 139
New N-alkanol-N-cyclohexanolamine aryl ester derivatives as reverting agents of Multidrug Resistance (MDR) 138
New quinoline derivatives as nicotinic receptor modulators 138
New potent piperazine and aminopiperidine derivatives as reverting agents of Multidrug Resistance (MDR) 136
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 135
Antinociceptive and antiamnesic properties of the nicotinic agonist AG-4 134
NEGATIVE INOTROPIC AND CALCIUM ANTAGONISTIC ACTIVITY OF ALKYL AND ARYLALKYL PHOSPHONATES 130
SEARCH FOR NEW CA2+ ANTAGONISTS. LIPOPHILIC OXIMES AND PHOSPHONATES 128
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 128
Design, Synthesis and binding affinity of carbachol dimers as bitopic ligands 127
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 126
Hybridized and isosteric analogs of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action 124
Design, Synthesis and binding affinity of new ligands for the central nicotinic receptors 123
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic acid and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer 123
SAR STUDIES IN THE FIELD OF CA2+ ANTAGONISTS. EFFECT OF MODIFICATIONS AT THE TETRASUBSTITUTED CARBON OF VERAPAMIL-LIKE COMPOUNDS 120
Design, synthesis and preliminary pharmacological evaluation of alkylderivatives of 4-aminopiperidine as N-type calcium channels blockers 120
Flavonoid aminoesters acting as reversing agents of Pgp-dependent multidrug resistance (MDR) 119
Sintesi e affinità per i recettori colinergici degli stereoisomeri della 1-metil-2-(2-metil-1,3-diossolan-4-il)pirrolidina, della 1-metil-2-(2-metil-1,3-ossatiolan-5-il)pirrolidina e dei loro iodometilati 114
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 114
New analogues of the potent nootropic drug DM235: 2-or 3-phenylpiperazines with limited conformational flexibility 112
Unexpected Multidrug Resistance (MDR) reverting activity of a new series of N,N-bis(arylalkanol)amine aryl esters 110
Unexpected agonistic activity in a series of muscarinic antagonists 91
Piperazine derivatives possessing nootropic activity 90
The double life of UNIFI nootropics 85
Progettazione, Sintesi e studio di molecular modeling di nuovi ligandi nicotinici 84
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 81
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 79
Pharmacological profile of the enantiomers of tropicamide 72
Totale 11.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022441 15 69 18 13 16 19 28 12 15 18 87 131
2022/20231.201 113 180 53 96 84 232 170 72 127 12 42 20
2023/2024651 8 50 76 31 24 60 17 315 7 23 17 23
2024/20252.843 99 291 192 413 825 456 24 189 102 58 101 93
2025/20262.982 313 415 235 160 345 146 344 153 190 201 66 414
2026/202715 15 0 0 0 0 0 0 0 0 0 0 0
Totale 11.271